Request for Covid-19 Impact Assessment of this Report
The United States Total Intravenous Anesthesia (TIVA) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Total Intravenous Anesthesia (TIVA) market, reaching US$ million by the year 2028. As for the Europe Total Intravenous Anesthesia (TIVA) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Total Intravenous Anesthesia (TIVA) players cover B. Braun Medical, Astrazeneca, Fresenius-Kabi, and AbbVie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Total Intravenous Anesthesia (TIVA) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Propofol
Etomidate
Midazolam
Barbiturates
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Predominantly Emergency
Orthopedic
Cosmetic Surgeries
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
B. Braun Medical
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Total Intravenous Anesthesia (TIVA) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Total Intravenous Anesthesia (TIVA) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Total Intravenous Anesthesia (TIVA) by Country/Region, 2017, 2022 & 2028
2.2 Total Intravenous Anesthesia (TIVA) Segment by Type
2.2.1 Propofol
2.2.2 Etomidate
2.2.3 Midazolam
2.2.4 Barbiturates
2.2.5 Others
2.3 Total Intravenous Anesthesia (TIVA) Sales by Type
2.3.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2017-2022)
2.3.2 Global Total Intravenous Anesthesia (TIVA) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Total Intravenous Anesthesia (TIVA) Sale Price by Type (2017-2022)
2.4 Total Intravenous Anesthesia (TIVA) Segment by Application
2.4.1 Predominantly Emergency
2.4.2 Orthopedic
2.4.3 Cosmetic Surgeries
2.4.4 Others
2.5 Total Intravenous Anesthesia (TIVA) Sales by Application
2.5.1 Global Total Intravenous Anesthesia (TIVA) Sale Market Share by Application (2017-2022)
2.5.2 Global Total Intravenous Anesthesia (TIVA) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Total Intravenous Anesthesia (TIVA) Sale Price by Application (2017-2022)
3 Global Total Intravenous Anesthesia (TIVA) by Company
3.1 Global Total Intravenous Anesthesia (TIVA) Breakdown Data by Company
3.1.1 Global Total Intravenous Anesthesia (TIVA) Annual Sales by Company (2020-2022)
3.1.2 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Company (2020-2022)
3.2 Global Total Intravenous Anesthesia (TIVA) Annual Revenue by Company (2020-2022)
3.2.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Company (2020-2022)
3.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Company (2020-2022)
3.3 Global Total Intravenous Anesthesia (TIVA) Sale Price by Company
3.4 Key Manufacturers Total Intravenous Anesthesia (TIVA) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Total Intravenous Anesthesia (TIVA) Product Location Distribution
3.4.2 Players Total Intravenous Anesthesia (TIVA) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Total Intravenous Anesthesia (TIVA) by Geographic Region
4.1 World Historic Total Intravenous Anesthesia (TIVA) Market Size by Geographic Region (2017-2022)
4.1.1 Global Total Intravenous Anesthesia (TIVA) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Total Intravenous Anesthesia (TIVA) Annual Revenue by Geographic Region
4.2 World Historic Total Intravenous Anesthesia (TIVA) Market Size by Country/Region (2017-2022)
4.2.1 Global Total Intravenous Anesthesia (TIVA) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Total Intravenous Anesthesia (TIVA) Annual Revenue by Country/Region
4.3 Americas Total Intravenous Anesthesia (TIVA) Sales Growth
4.4 APAC Total Intravenous Anesthesia (TIVA) Sales Growth
4.5 Europe Total Intravenous Anesthesia (TIVA) Sales Growth
4.6 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Growth
5 Americas
5.1 Americas Total Intravenous Anesthesia (TIVA) Sales by Country
5.1.1 Americas Total Intravenous Anesthesia (TIVA) Sales by Country (2017-2022)
5.1.2 Americas Total Intravenous Anesthesia (TIVA) Revenue by Country (2017-2022)
5.2 Americas Total Intravenous Anesthesia (TIVA) Sales by Type
5.3 Americas Total Intravenous Anesthesia (TIVA) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Total Intravenous Anesthesia (TIVA) Sales by Region
6.1.1 APAC Total Intravenous Anesthesia (TIVA) Sales by Region (2017-2022)
6.1.2 APAC Total Intravenous Anesthesia (TIVA) Revenue by Region (2017-2022)
6.2 APAC Total Intravenous Anesthesia (TIVA) Sales by Type
6.3 APAC Total Intravenous Anesthesia (TIVA) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Total Intravenous Anesthesia (TIVA) by Country
7.1.1 Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2017-2022)
7.1.2 Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2017-2022)
7.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Type
7.3 Europe Total Intravenous Anesthesia (TIVA) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Total Intravenous Anesthesia (TIVA) by Country
8.1.1 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2017-2022)
8.2 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Type
8.3 Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Total Intravenous Anesthesia (TIVA)
10.3 Manufacturing Process Analysis of Total Intravenous Anesthesia (TIVA)
10.4 Industry Chain Structure of Total Intravenous Anesthesia (TIVA)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Total Intravenous Anesthesia (TIVA) Distributors
11.3 Total Intravenous Anesthesia (TIVA) Customer
12 World Forecast Review for Total Intravenous Anesthesia (TIVA) by Geographic Region
12.1 Global Total Intravenous Anesthesia (TIVA) Market Size Forecast by Region
12.1.1 Global Total Intravenous Anesthesia (TIVA) Forecast by Region (2023-2028)
12.1.2 Global Total Intravenous Anesthesia (TIVA) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Total Intravenous Anesthesia (TIVA) Forecast by Type
12.7 Global Total Intravenous Anesthesia (TIVA) Forecast by Application
13 Key Players Analysis
13.1 B. Braun Medical
13.1.1 B. Braun Medical Company Information
13.1.2 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Offered
13.1.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 B. Braun Medical Main Business Overview
13.1.5 B. Braun Medical Latest Developments
13.2 Astrazeneca
13.2.1 Astrazeneca Company Information
13.2.2 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Offered
13.2.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Astrazeneca Main Business Overview
13.2.5 Astrazeneca Latest Developments
13.3 Fresenius-Kabi
13.3.1 Fresenius-Kabi Company Information
13.3.2 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Offered
13.3.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fresenius-Kabi Main Business Overview
13.3.5 Fresenius-Kabi Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Total Intravenous Anesthesia (TIVA) Product Offered
13.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Baxter Healthcare
13.5.1 Baxter Healthcare Company Information
13.5.2 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Offered
13.5.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Baxter Healthcare Main Business Overview
13.5.5 Baxter Healthcare Latest Developments
13.6 Maruishi
13.6.1 Maruishi Company Information
13.6.2 Maruishi Total Intravenous Anesthesia (TIVA) Product Offered
13.6.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Maruishi Main Business Overview
13.6.5 Maruishi Latest Developments
13.7 Piramal
13.7.1 Piramal Company Information
13.7.2 Piramal Total Intravenous Anesthesia (TIVA) Product Offered
13.7.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Piramal Main Business Overview
13.7.5 Piramal Latest Developments
13.8 Hikma Pharmaceuticals
13.8.1 Hikma Pharmaceuticals Company Information
13.8.2 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Offered
13.8.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hikma Pharmaceuticals Main Business Overview
13.8.5 Hikma Pharmaceuticals Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Total Intravenous Anesthesia (TIVA) Product Offered
13.9.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Nhwa
13.10.1 Nhwa Company Information
13.10.2 Nhwa Total Intravenous Anesthesia (TIVA) Product Offered
13.10.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Nhwa Main Business Overview
13.10.5 Nhwa Latest Developments
13.11 Hengrui
13.11.1 Hengrui Company Information
13.11.2 Hengrui Total Intravenous Anesthesia (TIVA) Product Offered
13.11.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hengrui Main Business Overview
13.11.5 Hengrui Latest Developments
13.12 Lunan
13.12.1 Lunan Company Information
13.12.2 Lunan Total Intravenous Anesthesia (TIVA) Product Offered
13.12.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Lunan Main Business Overview
13.12.5 Lunan Latest Developments
14 Research Findings and Conclusion
Table 1. Total Intravenous Anesthesia (TIVA) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Total Intravenous Anesthesia (TIVA) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Propofol
Table 4. Major Players of Etomidate
Table 5. Major Players of Midazolam
Table 6. Major Players of Barbiturates
Table 7. Major Players of Others
Table 8. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2017-2022) & (K Units)
Table 9. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2017-2022)
Table 10. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2017-2022) & ($ million)
Table 11. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2017-2022)
Table 12. Global Total Intravenous Anesthesia (TIVA) Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2017-2022) & (K Units)
Table 14. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2017-2022)
Table 15. Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2017-2022)
Table 16. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2017-2022)
Table 17. Global Total Intravenous Anesthesia (TIVA) Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Total Intravenous Anesthesia (TIVA) Sales by Company (2020-2022) & (K Units)
Table 19. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Company (2020-2022)
Table 20. Global Total Intravenous Anesthesia (TIVA) Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Company (2020-2022)
Table 22. Global Total Intravenous Anesthesia (TIVA) Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Total Intravenous Anesthesia (TIVA) Producing Area Distribution and Sales Area
Table 24. Players Total Intravenous Anesthesia (TIVA) Products Offered
Table 25. Total Intravenous Anesthesia (TIVA) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Total Intravenous Anesthesia (TIVA) Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Geographic Region (2017-2022)
Table 30. Global Total Intravenous Anesthesia (TIVA) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Total Intravenous Anesthesia (TIVA) Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Country/Region (2017-2022)
Table 34. Global Total Intravenous Anesthesia (TIVA) Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Total Intravenous Anesthesia (TIVA) Sales by Country (2017-2022) & (K Units)
Table 37. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2017-2022)
Table 38. Americas Total Intravenous Anesthesia (TIVA) Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2017-2022)
Table 40. Americas Total Intravenous Anesthesia (TIVA) Sales by Type (2017-2022) & (K Units)
Table 41. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2017-2022)
Table 42. Americas Total Intravenous Anesthesia (TIVA) Sales by Application (2017-2022) & (K Units)
Table 43. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2017-2022)
Table 44. APAC Total Intravenous Anesthesia (TIVA) Sales by Region (2017-2022) & (K Units)
Table 45. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2017-2022)
Table 46. APAC Total Intravenous Anesthesia (TIVA) Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2017-2022)
Table 48. APAC Total Intravenous Anesthesia (TIVA) Sales by Type (2017-2022) & (K Units)
Table 49. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2017-2022)
Table 50. APAC Total Intravenous Anesthesia (TIVA) Sales by Application (2017-2022) & (K Units)
Table 51. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2017-2022)
Table 52. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2017-2022) & (K Units)
Table 53. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2017-2022)
Table 54. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2017-2022)
Table 56. Europe Total Intravenous Anesthesia (TIVA) Sales by Type (2017-2022) & (K Units)
Table 57. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2017-2022)
Table 58. Europe Total Intravenous Anesthesia (TIVA) Sales by Application (2017-2022) & (K Units)
Table 59. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Total Intravenous Anesthesia (TIVA)
Table 69. Key Market Challenges & Risks of Total Intravenous Anesthesia (TIVA)
Table 70. Key Industry Trends of Total Intravenous Anesthesia (TIVA)
Table 71. Total Intravenous Anesthesia (TIVA) Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Total Intravenous Anesthesia (TIVA) Distributors List
Table 74. Total Intravenous Anesthesia (TIVA) Customer List
Table 75. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Total Intravenous Anesthesia (TIVA) Sales Market Forecast by Region
Table 77. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Total Intravenous Anesthesia (TIVA) Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Total Intravenous Anesthesia (TIVA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Total Intravenous Anesthesia (TIVA) Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Total Intravenous Anesthesia (TIVA) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Total Intravenous Anesthesia (TIVA) Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Total Intravenous Anesthesia (TIVA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Application (2023-2028)
Table 95. B. Braun Medical Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 96. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Offered
Table 97. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. B. Braun Medical Main Business
Table 99. B. Braun Medical Latest Developments
Table 100. Astrazeneca Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 101. Astrazeneca Total Intravenous Anesthesia (TIVA) Product Offered
Table 102. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Astrazeneca Main Business
Table 104. Astrazeneca Latest Developments
Table 105. Fresenius-Kabi Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 106. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Offered
Table 107. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Fresenius-Kabi Main Business
Table 109. Fresenius-Kabi Latest Developments
Table 110. AbbVie Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 111. AbbVie Total Intravenous Anesthesia (TIVA) Product Offered
Table 112. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. AbbVie Main Business
Table 114. AbbVie Latest Developments
Table 115. Baxter Healthcare Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 116. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Offered
Table 117. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Baxter Healthcare Main Business
Table 119. Baxter Healthcare Latest Developments
Table 120. Maruishi Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 121. Maruishi Total Intravenous Anesthesia (TIVA) Product Offered
Table 122. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Maruishi Main Business
Table 124. Maruishi Latest Developments
Table 125. Piramal Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 126. Piramal Total Intravenous Anesthesia (TIVA) Product Offered
Table 127. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Piramal Main Business
Table 129. Piramal Latest Developments
Table 130. Hikma Pharmaceuticals Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Offered
Table 132. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Hikma Pharmaceuticals Main Business
Table 134. Hikma Pharmaceuticals Latest Developments
Table 135. Mylan Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 136. Mylan Total Intravenous Anesthesia (TIVA) Product Offered
Table 137. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Mylan Main Business
Table 139. Mylan Latest Developments
Table 140. Nhwa Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 141. Nhwa Total Intravenous Anesthesia (TIVA) Product Offered
Table 142. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Nhwa Main Business
Table 144. Nhwa Latest Developments
Table 145. Hengrui Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 146. Hengrui Total Intravenous Anesthesia (TIVA) Product Offered
Table 147. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Hengrui Main Business
Table 149. Hengrui Latest Developments
Table 150. Lunan Basic Information, Total Intravenous Anesthesia (TIVA) Manufacturing Base, Sales Area and Its Competitors
Table 151. Lunan Total Intravenous Anesthesia (TIVA) Product Offered
Table 152. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. Lunan Main Business
Table 154. Lunan Latest Developments
List of Figures
Figure 1. Picture of Total Intravenous Anesthesia (TIVA)
Figure 2. Total Intravenous Anesthesia (TIVA) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Total Intravenous Anesthesia (TIVA) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Total Intravenous Anesthesia (TIVA) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Total Intravenous Anesthesia (TIVA) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Propofol
Figure 10. Product Picture of Etomidate
Figure 11. Product Picture of Midazolam
Figure 12. Product Picture of Barbiturates
Figure 13. Product Picture of Others
Figure 14. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type in 2021
Figure 15. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2017-2022)
Figure 16. Total Intravenous Anesthesia (TIVA) Consumed in Predominantly Emergency
Figure 17. Global Total Intravenous Anesthesia (TIVA) Market: Predominantly Emergency (2017-2022) & (K Units)
Figure 18. Total Intravenous Anesthesia (TIVA) Consumed in Orthopedic
Figure 19. Global Total Intravenous Anesthesia (TIVA) Market: Orthopedic (2017-2022) & (K Units)
Figure 20. Total Intravenous Anesthesia (TIVA) Consumed in Cosmetic Surgeries
Figure 21. Global Total Intravenous Anesthesia (TIVA) Market: Cosmetic Surgeries (2017-2022) & (K Units)
Figure 22. Total Intravenous Anesthesia (TIVA) Consumed in Others
Figure 23. Global Total Intravenous Anesthesia (TIVA) Market: Others (2017-2022) & (K Units)
Figure 24. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2017-2022)
Figure 25. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application in 2021
Figure 26. Total Intravenous Anesthesia (TIVA) Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Company in 2021
Figure 28. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Geographic Region in 2021
Figure 30. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2017-2022)
Figure 31. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country/Region in 2021
Figure 32. Americas Total Intravenous Anesthesia (TIVA) Sales 2017-2022 (K Units)
Figure 33. Americas Total Intravenous Anesthesia (TIVA) Revenue 2017-2022 ($ Millions)
Figure 34. APAC Total Intravenous Anesthesia (TIVA) Sales 2017-2022 (K Units)
Figure 35. APAC Total Intravenous Anesthesia (TIVA) Revenue 2017-2022 ($ Millions)
Figure 36. Europe Total Intravenous Anesthesia (TIVA) Sales 2017-2022 (K Units)
Figure 37. Europe Total Intravenous Anesthesia (TIVA) Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue 2017-2022 ($ Millions)
Figure 40. Americas Total Intravenous Anesthesia (TIVA) Sales Market Share by Country in 2021
Figure 41. Americas Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country in 2021
Figure 42. United States Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Total Intravenous Anesthesia (TIVA) Sales Market Share by Region in 2021
Figure 47. APAC Total Intravenous Anesthesia (TIVA) Revenue Market Share by Regions in 2021
Figure 48. China Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country in 2021
Figure 55. Europe Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country in 2021
Figure 56. Germany Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country in 2021
Figure 63. Egypt Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Total Intravenous Anesthesia (TIVA) Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Total Intravenous Anesthesia (TIVA) in 2021
Figure 69. Manufacturing Process Analysis of Total Intravenous Anesthesia (TIVA)
Figure 70. Industry Chain Structure of Total Intravenous Anesthesia (TIVA)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...